Recent ENFN Stock Price | ENFN Stock Predictions | |
$9.42 | +3.08% |
$9.71 |
Recent ENFN Analyst Ratings Breakdown, Making ENFN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 2 | 3 | 4 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 2 | 2 | 1 | 0 |
Average rating: | 2.88 | 2.88 | 2.63 | 2.38 |
For the ENFN stock predictions from the analysts covering Enfusion Inc, we have collected all of the individual ENFN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering ENFN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ENFN stock predictions may vary widely, another useful metric to consider is the median ENFN stock prediction, which represents the price at which half of the analysts
made ENFN stock predictions that were higher and half made ENFN stock predictions that were lower. This makes for a different take on the ENFN stock predictions out there, as compared to average or mean.
And that median across all the individual ENFN stock predictions was: $9.0 as of 2024-04-29.
The very highest of the ENFN stock predictions for one year price target was $12.0, while the very lowest of the ENFN stock predictions in the analyst group was
$8.0 (with a standard deviation of $1.38). Get the latest Zacks research report on ENFN — FREE
Find out: ENFN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
OLN Stock Predictions
CNNE Stock Predictions
SSRM Stock Predictions
STAG Stock Predictions
EGO Stock Predictions
GFI Stock Predictions
PAM Stock Predictions
COP Stock Predictions
BDGE Stock Predictions
|
|
Hold (2.12 out of 4) 3rd percentile
(ranked lower than approx. 97% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |